Drug for Batten disease gets orphan status

04:58 EDT 9 Aug 2017 | SmartBrief

The FDA gave orphan drug status to Polaryx Therapeutics' drug candidate PLX-200 to treat late infantile neuronal ceroid lipof -More

Original Article: Drug for Batten disease gets orphan status


More From BioPortfolio on "Drug for Batten disease gets orphan status"

Quick Search

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...